acetaminophen glucuronide has been researched along with Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruschi, SA; Eaton, DL; Kalhorn, T; Kelly, EJ; Nebert, DW; Nelson, SD; Tonge, RP | 1 |
| Hazelton, GA; Hjelle, JJ; Klaassen, CD | 1 |
2 other study(ies) available for acetaminophen glucuronide and Liver Diseases
| Article | Year |
|---|---|
Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null mice.
Topics: Acetaminophen; Alanine Transaminase; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP1A2; Liver; Liver Diseases; Male; Mice; Mice, Knockout | 1998 |
Effects of butylated hydroxyanisole on acetaminophen hepatotoxicity and glucuronidation in vivo.
Topics: Acetaminophen; Alanine; Animals; Anisoles; Aspartate Aminotransferases; Biotransformation; Butylated Hydroxyanisole; Chemical and Drug Induced Liver Injury; Female; Glucuronosyltransferase; Glutathione; Kinetics; Liver Diseases; Mice; Protein Binding; Uridine Diphosphate Glucose Dehydrogenase; Uridine Diphosphate Glucuronic Acid | 1986 |